Diagnosis and management of red eye in primary care

American Family Physician

Volumn 81, Issue 2, 2010, Pages 137-144

  Cronau, Holly ^a,b   Kankanala, Ramana Reddy ^a   Mauger, Thomas ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Department's Family Medicine Clerkship   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALAWAY; ANTIBIOTIC AGENT; AZASITE; AZELASTINE; AZITHROMYCIN; BESIFLOXACIN; BESIVANCE; CIPROFLOXACIN; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYCLOSPORIN; CYCLOSPORIN A; DOXYCYCLINE; EMEDASTINE; ERYTHROMYCIN; GATIFLOXACIN; GENTAK; GENTAMICIN; IQUIX; KETOROLAC TROMETAMOL; KETOTIFEN FUMARATE; LEVOFLOXACIN; LODOXAMIDE TROMETAMOL; LUBRICATING AGENT; MOXIFLOXACIN; NAPHAZOLINE; NEDOCROMIL SODIUM; OFLOXACIN; OLOPATADINE; OPCON A; PHENIRAMINE; POLYTRIM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFACETAMIDE; TETRYZOLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLERGIC CONJUNCTIVITIS; BEDTIME DOSAGE; BLEPHARITIS; CLINICAL TRIAL; CONJUNCTIVAL HEMORRHAGE; CONJUNCTIVITIS; CORNEA INJURY; DRUG COST; DRY EYE; EPISCLERITIS; EYE SURGERY; HUMAN; INTRAOCULAR DRUG ADMINISTRATION; PRIMARY MEDICAL CARE; REVIEW; TRACHOMA; VIRAL CONJUNCTIVITIS; VISUAL IMPAIRMENT;

EID: 75849122316     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Petersen I, Hayward AC. Antibacterial prescribing in primary care. J Antimicrob Chemother. 2007;60(suppl 1):i43-47.
2. Høvding G. Acute bacterial conjunctivitis. Acta Ophthalmol. 2008; 86(1):5-17.
3. Wirbelauer C. Management of the red eye for the primary care physician. Am J Med. 2006;119(4):302-306.
4. Leibowitz HM. The red eye. N Engl J Med. 2000;343(5):345-351.
5. Galor A, Jeng BH. Red eye for the internist: when to treat, when to refer. Cleve Clin J Med. 2008;75(2):137-144.
6. Rietveld RP, ter Riet G, Bindels PJ, et al. Predicting bacterial cause in infectious conjunctivitis. BMJ. 2004;329(7459):206-210.
7. Rose PW, Harnden A, Brueggemann AB, et al. Chloramphenicol treatment for acute infective conjunctivitis in children in primary care. Lancet. 2005;366(9479):37-43.
8. Rietveld RP, van Weert HC, ter Riet G, et al. Diagnostic impact of signs and symptoms in acute infectious conjunctivitis. BMJ. 2003;327(7418):789.
9. Everitt HA, Little PS, Smith PW. A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice [published correction appears in BMJ. 2006;333(7566):468]. BMJ. 2006;333(7563):321.
10. Wagner RS, Aquino M. Pediatric ocular inflammation. Immunol Allergy Clin North Am. 2008;28(1):169-188.
11. Buznach N, Dagan R, Greenberg D. Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era. Pediatr Infect Dis J. 2005;24(9):823-828.
12. Morrow GL, Abbott RL. Conjunctivitis. Am Fam Physician. 1998;57(4): 735-746.
13. Azar MJ, Dhaliwal DK, Bower KS, et al. Possible consequences of shaking hands with your patients with epidemic keratoconjunctivitis. Am J Ophthalmol. 1996;121(6):711-712.
14. Fay A. Diseases of the visual system. In: Goldman L, Ausillo D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa.: Saunders; 2007.
15. American Academy of Ophthalmology. Preferred practice patterns. Conjunctivitis. September 2008. http://one.aao.org/CE/PracticeGuidelines/PPP. aspx. Accessed September 3, 2009.
16. Sheikh A, Hurwitz B. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev. 2006(2):CD001211.
17. Sheikh A, Hurwitz B. Topical antibiotics for acute bacterial conjunctivitis. Br J Gen Pract. 2005;55(521):962-964.
18. Sheikh A, Hurwitz B. Topical antibiotics for acute bacterial conjunctivitis: a systematic review. Br J Gen Pract. 2001;51(467):473- 477.
19. Wickström K. Acute bacterial conjunctivitis - benefits versus risks with antibiotic treatment. Acta Ophthalmol. 2008;86(1):2-4.
20. Block SL, Hedrick J, Tyler R, et al. Increasing bacterial resistance in pediatric acute conjunctivitis. Antimicrob Agents Chemother. 2000;44(6):1650-1654.
21. Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis. Ophthalmology. 1999;106(7):1313-1318.
22. Little P, Gould C, Williamson I, et al. Reattendance and complications in a randomised trial of prescribing strategies for sore throat. BMJ. 1997;315(7104):350-352.
23. Trimethoprim-polymyxin B sulphate ophthalmic ointment versus chloramphenicol ophthalmic ointment in the treatment of bacterial conjunctivitis. J Antimicrob Chemother. 1989;23(2):261-266.
24. Jauch A, Fsadni M, Gamba G. Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis. Graefes Arch Clin Exp Ophthalmol. 1999;237(9):705-713.
25. Lohr JA, Austin RD, Grossman M, et al. Comparison of three topical antimicrobials for acute bacterial conjunctivitis. Pediatr Infect Dis J. 1988;7(9):626-629.
26. Protzko E, Bowman L, Abelson M, et al. Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis. Invest Ophthalmol Vis Sci. 2007;48(8):3425-3429.
27. Bielory L, Friedlaender MH. Allergic conjunctivitis. Immunol Allergy Clin North Am. 2008;28(1):43-58.
28. Granet D. Allergic rhinoconjunctivitis and differential diagnosis of the red eye. Allergy Asthma Proc. 2008;29(6):565-574.
29. Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalance of dry eye syndrome among U.S. women. Am J Ophthalmol. 2003;136(2):318-326.
30. Jackson WB. Blepharitis: current strategies for diagnosis and management. Can J Ophthalmol. 2008;43(2):170-179.
31. Tomlinson A, Khanal S, Ramaesh K, et al. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci. 2006;47(10):4309-4315.
32. American Academy of Ophthalmology. Preferred practice patterns. Dry eye syndrome. http://one.aao.org/CE/PracticeGuidelines/PPP.aspx. Accessed September 3, 2009.
33. American Academy of Ophthalmology. Preferred practice pattern. Blepharitis. http://one.aao.org/CE/PracticeGuidelines/PPP.aspx. Accessed September 3, 2009.
34. Tullo A. Pathogenesis and management of herpes simplex virus keratitis. Eye. 2003;17(8):919-922.
35. Turner A, Rabiu M. Patching for corneal abrasion. Cochrane Database Syst Rev. 2006(2):CD004764.
36. Williams CP, Browning AC, Sleep TJ, et al. A randomised, double-blind trial of topical ketorolac vs artificial tears for the treatment of episcleritis. Eye. 2005;19(7):739-742.